Publications

Publications published since 2003 by Mathias Toft

71 publications found

Publications 2019

  1. Blauwendraat C, Heilbron K, Vallerga CL, Bandres-Ciga S, von Coelln R, Pihlstrøm L, Simón-Sánchez J, Schulte C, Sharma M, Krohn L, Siitonen A, Iwaki H, Leonard H, Noyce AJ, Tan M, Gibbs JR, Hernandez DG, Scholz SW, Jankovic J, Shulman LM, Lesage S, Corvol JC, Brice A, van Hilten JJ, Marinus J et al. (2019)
    Parkinson's disease age at onset genome-wide association study: Defining heritability, genetic loci, and α-synuclein mechanisms
    Mov Disord, 34 (6), 866-875
    DOI 10.1002/mds.27659, PubMed 30957308
  2. Flengsrud K, Toft M, Dietrichs E (2019)
    Essential tremor
    Tidsskr Nor Laegeforen, 139 (8)
    DOI 10.4045/tidsskr.18.0904, PubMed 31062562
  3. Flengsrud K, Toft M, Dietrichs E (2019)
    Essential tremor
    Tidsskr. Nor. Laegeforen., 139 (8), 722-725
  4. Iqbal Z, Toft M (2019)
    TMEM230 variants in Parkinson's disease
    Nat Genet, 51 (3), 366
    DOI 10.1038/s41588-019-0353-7, PubMed 30804555
  5. Rongve A, Witoelar A, Ruiz A, Athanasiu L, Abdelnour C, Clarimon J, Heilmann-Heimbach S, Hernández I, Moreno-Grau S, de Rojas I, Morenas-Rodríguez E, Fladby T, Sando SB, Bråthen G, Blanc F, Bousiges O, Lemstra AW, van Steenoven I, Londos E, Almdahl IS, Pålhaugen L, Eriksen JA, Djurovic S, Stordal E, Saltvedt I et al. (2019)
    GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study
    Sci Rep, 9 (1), 7013
    DOI 10.1038/s41598-019-43458-2, PubMed 31065058

Publications 2018

  1. Berge-Seidl V, Pihlstrøm L, Wszolek ZK, Ross OA, Toft M (2018)
    No evidence for DNM3 as genetic modifier of age at onset in idiopathic Parkinson's disease
    Neurobiol Aging, 74, 236.e1-236.e5
    DOI 10.1016/j.neurobiolaging.2018.09.022, PubMed 30340792
  2. Bjerknes S, Toft M, Konglund AE, Pham U, Waage TR, Pedersen L, Skjelland M, Haraldsen I, Andersson S, Dietrichs E, Skogseid IM (2018)
    Multiple Microelectrode Recordings in STN-DBS Surgery for Parkinson's Disease: A Randomized Study
    Mov Disord Clin Pract, 5 (3), 296-305
    DOI 10.1002/mdc3.12621, PubMed 30009214
  3. Bjørnarå KA, Pihlstrøm L, Dietrichs E, Toft M (2018)
    Risk variants of the α-synuclein locus and REM sleep behavior disorder in Parkinson's disease: a genetic association study
    BMC Neurol, 18 (1), 20
    DOI 10.1186/s12883-018-1023-6, PubMed 29466944
  4. Blauwendraat C, Reed X, Kia DA, Gan-Or Z, Lesage S, Pihlstrøm L, Guerreiro R, Gibbs JR, Sabir M, Ahmed S, Ding J, Alcalay RN, Hassin-Baer S, Pittman AM, Brooks J, Edsall C, Hernandez DG, Chung SJ, Goldwurm S, Toft M, Schulte C, Bras J, Wood NW, Brice A, Morris HR et al. (2018)
    Frequency of Loss of Function Variants in LRRK2 in Parkinson Disease
    JAMA Neurol, 75 (11), 1416-1422
    DOI 10.1001/jamaneurol.2018.1885, PubMed 30039155
  5. Kristiansen M, Maple-Grødem J, Alves G, Arepalli S, Hernandez DG, Iwaki H, Nalls MA, Singleton A, Tysnes OB, Toft M, Pihlstrøm L (2018)
    A paradoxical relationship between family history, onset age, and genetic risk in Parkinson's disease
    Mov Disord, 34 (2), 298-299
    DOI 10.1002/mds.27555, PubMed 30484896
  6. Pihlstrøm L, Blauwendraat C, Cappelletti C, Berge-Seidl V, Langmyhr M, Henriksen SP, van de Berg WDJ, Gibbs JR, Cookson MR, International Parkinson Disease Genomics Consortium, North American Brain Expression Consortium, Singleton AB, Nalls MA, Toft M (2018)
    A comprehensive analysis of SNCA-related genetic risk in sporadic parkinson disease
    Ann Neurol, 84 (1), 117-129
    DOI 10.1002/ana.25274, PubMed 30146727

Publications 2017

  1. Berge-Seidl V, Pihlstrøm L, Maple-Grødem J, Forsgren L, Linder J, Larsen JP, Tysnes OB, Toft M (2017)
    The GBA variant E326K is associated with Parkinson's disease and explains a genome-wide association signal
    Neurosci Lett, 658, 48-52
    DOI 10.1016/j.neulet.2017.08.040, PubMed 28830825
  2. Blauwendraat C, Kia DA, Pihlstrøm L, Gan-Or Z, Lesage S, Gibbs JR, Ding J, Alcalay RN, Hassin-Baer S, Pittman AM, Brooks J, Edsall C, Chung SJ, Goldwurm S, Toft M, Schulte C, International Parkinson's Disease Genomics Consortium (IPDGC), COURAGE-PD Consortium, Hernandez D, Singleton AB, Nalls MA, Brice A, Scholz SW, Wood NW (2017)
    Insufficient evidence for pathogenicity of SNCA His50Gln (H50Q) in Parkinson's disease
    Neurobiol Aging, 64, 159.e5-159.e8
    DOI 10.1016/j.neurobiolaging.2017.12.012, PubMed 29398121
  3. Iqbal Z, Rydning SL, Wedding IM, Koht J, Pihlstrøm L, Rengmark AH, Henriksen SP, Tallaksen CM, Toft M (2017)
    Targeted high throughput sequencing in hereditary ataxia and spastic paraplegia
    PLoS One, 12 (3), e0174667
    DOI 10.1371/journal.pone.0174667, PubMed 28362824
  4. Iqbal Z, Rydning SL, Wedding IM, Koht J, Pihlstrøm L, Rengmark AH, Henriksen SP, Tallaksen CME, Toft M (2017)
    Correction: Targeted high throughput sequencing in hereditary ataxia and spastic paraplegia
    PLoS One, 12 (10), e0186571
    DOI 10.1371/journal.pone.0186571, PubMed 29023604

Publications 2016

  1. Iqbal Z, Pihlstrøm L, Rengmark A, Henriksen SP, Linder J, Forsgren L, Toft M (2016)
    Rare variants in dementia genes and Parkinson's disease
    Eur J Hum Genet, 24 (12), 1661-1662
    DOI 10.1038/ejhg.2016.79, PubMed 27329738
  2. Pihlstrøm L, Morset KR, Grimstad E, Vitelli V, Toft M (2016)
    A cumulative genetic risk score predicts progression in Parkinson's disease
    Mov Disord, 31 (4), 487-90
    DOI 10.1002/mds.26505, PubMed 26853697
  3. Rengmark A, Pihlstrøm L, Linder J, Forsgren L, Toft M (2016)
    Low frequency of GCH1 and TH mutations in Parkinson's disease
    Parkinsonism Relat Disord, 29, 109-11
    DOI 10.1016/j.parkreldis.2016.05.010, PubMed 27185167
  4. Toft M, Ross OA (2016)
    Exome Variant Mining in Familial Parkinson Disease: Will Replication Find the Gold?
    JAMA Neurol, 73 (1), 21-2
    DOI 10.1001/jamaneurol.2015.3536, PubMed 26595415

Publications 2015

  1. Iqbal Z, Toft M (2015)
    CHCHD2 and Parkinson's disease
    Lancet Neurol, 14 (7), 680-1
    DOI 10.1016/S1474-4422(15)00096-4, PubMed 26067113
  2. Lill CM, Rengmark A, Pihlstrøm L, Fogh I, Shatunov A, Sleiman PM, Wang LS, Liu T, Lassen CF, Meissner E, Alexopoulos P, Calvo A, Chio A, Dizdar N, Faltraco F, Forsgren L, Kirchheiner J, Kurz A, Larsen JP, Liebsch M, Linder J, Morrison KE, Nissbrandt H, Otto M, Pahnke J et al. (2015)
    The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease
    Alzheimers Dement, 11 (12), 1407-1416
    DOI 10.1016/j.jalz.2014.12.009, PubMed 25936935
  3. Pham U, Solbakk AK, Skogseid IM, Toft M, Pripp AH, Konglund AE, Andersson S, Haraldsen IR, Aarsland D, Dietrichs E, Malt UF (2015)
    Personality changes after deep brain stimulation in Parkinson's disease
    Parkinsons Dis, 2015, 490507
    DOI 10.1155/2015/490507, PubMed 25705545
  4. Pham UH, Andersson S, Toft M, Pripp AH, Konglund AE, Dietrichs E, Malt UF, Skogseid IM, Haraldsen IR, Solbakk AK (2015)
    Self-Reported Executive Functioning in Everyday Life in Parkinson's Disease after Three Months of Subthalamic Deep Brain Stimulation
    Parkinsons Dis, 2015, 461453
    DOI 10.1155/2015/461453, PubMed 26167329
  5. Pihlstrøm L, Rengmark A, Bjørnarå KA, Dizdar N, Fardell C, Forsgren L, Holmberg B, Larsen JP, Linder J, Nissbrandt H, Tysnes OB, Dietrichs E, Toft M (2015)
    Fine mapping and resequencing of the PARK16 locus in Parkinson's disease
    J Hum Genet, 60 (7), 357-62
    DOI 10.1038/jhg.2015.34, PubMed 25855069
  6. Pihlstrøm L, Toft M (2015)
    Cumulative genetic risk and age at onset in Parkinson's disease
    Mov Disord, 30 (12), 1712-3
    DOI 10.1002/mds.26366, PubMed 26234887
  7. Wang L, Aasly JO, Annesi G, Bardien S, Bozi M, Brice A, Carr J, Chung SJ, Clarke C, Crosiers D, Deutschländer A, Eckstein G, Farrer MJ, Goldwurm S, Garraux G, Hadjigeorgiou GM, Hicks AA, Hattori N, Klein C, Jeon B, Kim YJ, Lesage S, Lin JJ, Lynch T, Lichtner P et al. (2015)
    Large-scale assessment of polyglutamine repeat expansions in Parkinson disease
    Neurology, 85 (15), 1283-92
    DOI 10.1212/WNL.0000000000002016, PubMed 26354989

Publications 2014

  1. Bjerknes S, Skogseid IM, Sæhle T, Dietrichs E, Toft M (2014)
    Surgical site infections after deep brain stimulation surgery: frequency, characteristics and management in a 10-year period
    PLoS One, 9 (8), e105288
    DOI 10.1371/journal.pone.0105288, PubMed 25122445
  2. Bjørnarå KA, Dietrichs E, Toft M (2014)
    Clinical features associated with sleep disturbances in Parkinson's disease
    Clin Neurol Neurosurg, 124, 37-43
    DOI 10.1016/j.clineuro.2014.06.027, PubMed 25016237
  3. Børretzen MN, Bjerknes S, Sæhle T, Skjelland M, Skogseid IM, Toft M, Dietrichs E (2014)
    Long-term follow-up of thalamic deep brain stimulation for essential tremor - patient satisfaction and mortality
    BMC Neurol, 14, 120
    DOI 10.1186/1471-2377-14-120, PubMed 24903550
  4. Koht J, Rengmark A, Opladen T, Bjørnarå KA, Selberg T, Tallaksen CM, Blau N, Toft M (2014)
    Clinical and genetic studies in a family with a novel mutation in the sepiapterin reductase gene
    Acta Neurol Scand Suppl (198), 7-12
    DOI 10.1111/ane.12230, PubMed 24588500
  5. Lilleeng B, Brønnick K, Toft M, Dietrichs E, Larsen JP (2014)
    Progression and survival in Parkinson's disease with subthalamic nucleus stimulation
    Acta Neurol Scand, 130 (5), 292-8
    DOI 10.1111/ane.12224, PubMed 24495107
  6. Pihlstrøm L, Berge V, Rengmark A, Toft M (2014)
    Parkinson's disease correlates with promoter methylation in the α-synuclein gene
    Mov Disord, 30 (4), 577-80
    DOI 10.1002/mds.26073, PubMed 25545759
  7. Pihlstrøm L, Rengmark A, Bjørnarå KA, Toft M (2014)
    Effective variant detection by targeted deep sequencing of DNA pools: an example from Parkinson's disease
    Ann Hum Genet, 78 (3), 243-52
    DOI 10.1111/ahg.12060, PubMed 24660942
  8. Toft M (2014)
    Advances in genetic diagnosis of neurological disorders
    Acta Neurol Scand Suppl (198), 20-5
    DOI 10.1111/ane.12232, PubMed 24588502

Publications 2013

  1. Karlsson MK, Sharma P, Aasly J, Toft M, Skogar O, Sæbø S, Lönneborg A (2013)
    Found in transcription: accurate Parkinson's disease classification in peripheral blood
    J Parkinsons Dis, 3 (1), 19-29
    DOI 10.3233/JPD-120159, PubMed 23938308
  2. Toft M, Dietrichs E (2013)
    Medication costs following subthalamic nucleus deep brain stimulation for Parkinson's disease
    Mov Disord, 29 (2), 275-6
    DOI 10.1002/mds.25504, PubMed 23696136

Publications 2012

  1. Bjørnarå KA, Dietrichs E, Toft M (2012)
    REM sleep behavior disorder in Parkinson's disease--is there a gender difference?
    Parkinsonism Relat Disord, 19 (1), 120-2
    DOI 10.1016/j.parkreldis.2012.05.027, PubMed 22726815
  2. Pihlstrøm L, Axelsson G, Bjørnarå KA, Dizdar N, Fardell C, Forsgren L, Holmberg B, Larsen JP, Linder J, Nissbrandt H, Tysnes OB, Ohman E, Dietrichs E, Toft M (2012)
    Supportive evidence for 11 loci from genome-wide association studies in Parkinson's disease
    Neurobiol Aging, 34 (6), 1708.e7-13
    DOI 10.1016/j.neurobiolaging.2012.10.019, PubMed 23153929

Publications 2011

  1. Pihlstrøm L, Toft M (2011)
    Genetic variability in SNCA and Parkinson's disease
    Neurogenetics, 12 (4), 283-93
    DOI 10.1007/s10048-011-0292-7, PubMed 21800132
  2. Pihlstrøm L, Toft M (2011)
    Parkinson's disease: What remains of the "missing heritability"?
    Mov Disord, 26 (11), 1971-3
    DOI 10.1002/mds.23898, PubMed 21812035
  3. Toft M (2011)
    The Wilson films--MS tremor
    Mov Disord, 26 (14), 2471-2
    DOI 10.1002/mds.24010, PubMed 22170271
  4. Toft M (2011)
    Dopaminergic Neurons Generated Directly From Human Fibroblasts
    Mov. Disord., 26 (11), 1975
  5. Toft M (2011)
    International consortium identifies new genetic risk factors for Parkinson's disease
    Mov Disord, 26 (4), 606
    DOI 10.1002/mds.23725, PubMed 21648125
  6. Toft M, Dietrichs E (2011)
    Aggravated stuttering following subthalamic deep brain stimulation in Parkinson's disease--two cases
    BMC Neurol, 11, 44
    DOI 10.1186/1471-2377-11-44, PubMed 21477305
  7. Toft M, Dietrichs E (2011)
    Levodopa-responsive parkinsonism in probable extrapontine myelinolysis of the mesencephalon
    Mov Disord, 26 (12), 2180-1
    DOI 10.1002/mds.23876, PubMed 22021157
  8. Toft M, Lilleeng B, Ramm-Pettersen J, Skogseid IM, Gundersen V, Gerdts R, Pedersen L, Skjelland M, Røste GK, Dietrichs E (2011)
    Long-term efficacy and mortality in Parkinson's disease patients treated with subthalamic stimulation
    Mov Disord, 26 (10), 1931-4
    DOI 10.1002/mds.23817, PubMed 21656853

Publications 2010

  1. Toft M, Ross OA (2010)
    Copy number variation in Parkinson's disease
    Genome Med, 2 (9), 62
    DOI 10.1186/gm183, PubMed 20828427
  2. Aasly JO, Vilariño-Güell C, Dachsel JC, Webber PJ, West AB, Haugarvoll K, Johansen KK, Toft M, Nutt JG, Payami H, Kachergus JM, Lincoln SJ, Felic A, Wider C, Soto-Ortolaza AI, Cobb SA, White LR, Ross OA, Farrer MJ (2010)
    Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's disease
    Mov Disord, 25 (13), 2156-63
    DOI 10.1002/mds.23265, PubMed 20669305

Publications 2008

  1. Haugarvoll K, Toft M, Skipper L, Heckman MG, Crook JE, Soto A, Ross OA, Hulihan MM, Kachergus JM, Sando SB, White LR, Lynch T, Gibson JM, Uitti RJ, Wszolek ZK, Aasly JO, Farrer MJ (2008)
    Fine-mapping and candidate gene investigation within the PARK10 locus
    Eur J Hum Genet, 17 (3), 336-43
    DOI 10.1038/ejhg.2008.187, PubMed 18854859
  2. Ross OA, Toft M, Haugarvoll K (2008)
    Corticobasal syndrome and primary progressive aphasia as manifestations of lrrk2 gene mutations
    Neurology, 71 (4), 303; author reply 303-4
    DOI 10.1212/01.wnl.0000320511.30222.dd, PubMed 18645174
  3. Toft M, Lilleeng B, Ramm-Pettersen J, Røste GK, Pedersen L, Skogseid IM, Dietrichs E (2008)
    [Treatment of movement disorders with deep brain stimulation]
    Tidsskr Nor Laegeforen, 128 (17), 1972-6
    PubMed 18787575

Publications 2007

  1. Haugarvoll K, Toft M, Ross OA, Stone JT, Heckman MG, White LR, Lynch T, Gibson JM, Wszolek ZK, Uitti RJ, Aasly JO, Farrer MJ (2007)
    ELAVL4, PARK10, and the Celts
    Mov Disord, 22 (4), 585-7
    DOI 10.1002/mds.21336, PubMed 17230446
  2. Haugarvoll K, Toft M, Ross OA, White LR, Aasly JO, Farrer MJ (2007)
    Variants in the LRRK1 gene and susceptibility to Parkinson's disease in Norway
    Neurosci Lett, 416 (3), 299-301
    DOI 10.1016/j.neulet.2007.02.020, PubMed 17324517
  3. Toft M (2007)
    A patient's journey - The reluctant patient: Parkinson's disease - A doctor's perspective
    Br. Med. J., 335 (7627), 990
  4. Toft M, Mata IF, Ross OA, Kachergus J, Hulihan MM, Haugarvoll K, Stone JT, Blazquez M, Gibson JM, Aasly JO, White LR, Lynch T, Adler CH, Gwinn-Hardy K, Farrer MJ (2007)
    Pathogenicity of the Lrrk2 R1514Q substitution in Parkinson's disease
    Mov Disord, 22 (3), 389-92
    DOI 10.1002/mds.21217, PubMed 17216639
  5. White LR, Toft M, Kvam SN, Farrer MJ, Aasly JO (2007)
    MAPK-pathway activity, Lrrk2 G2019S, and Parkinson's disease
    J Neurosci Res, 85 (6), 1288-94
    DOI 10.1002/jnr.21240, PubMed 17385669

Publications 2006

  1. Dächsel JC, Ross OA, Mata IF, Kachergus J, Toft M, Cannon A, Baker M, Adamson J, Hutton M, Dickson DW, Farrer MJ (2006)
    Lrrk2 G2019S substitution in frontotemporal lobar degeneration with ubiquitin-immunoreactive neuronal inclusions
    Acta Neuropathol, 113 (5), 601-6
    DOI 10.1007/s00401-006-0178-1, PubMed 17151837
  2. Farrer MJ, Haugarvoll K, Ross OA, Stone JT, Milkovic NM, Cobb SA, Whittle AJ, Lincoln SJ, Hulihan MM, Heckman MG, White LR, Aasly JO, Gibson JM, Gosal D, Lynch T, Wszolek ZK, Uitti RJ, Toft M (2006)
    Genomewide association, Parkinson disease, and PARK10
    Am J Hum Genet, 78 (6), 1084-8; author reply 1092-4
    DOI 10.1086/504728, PubMed 16685661
  3. Papapetropoulos S, Singer C, Ross OA, Toft M, Johnson JL, Farrer MJ, Mash DC (2006)
    Clinical heterogeneity of the LRRK2 G2019S mutation
    Arch Neurol, 63 (9), 1242-6
    DOI 10.1001/archneur.63.9.1242, PubMed 16966501
  4. Ross OA, Toft M, Whittle AJ, Johnson JL, Papapetropoulos S, Mash DC, Litvan I, Gordon MF, Wszolek ZK, Farrer MJ, Dickson DW (2006)
    Lrrk2 and Lewy body disease
    Ann Neurol, 59 (2), 388-93
    DOI 10.1002/ana.20731, PubMed 16437559

Publications 2005

  1. Biancalana V, Toft M, Le Ber I, Tison F, Scherrer E, Thibodeau S, Mandel JL, Brice A, Farrer MJ, Dürr A (2005)
    FMR1 premutations associated with fragile X-associated tremor/ataxia syndrome in multiple system atrophy
    Arch Neurol, 62 (6), 962-6
    DOI 10.1001/archneur.62.6.962, PubMed 15956167
  2. Gosal D, Ross OA, Wiley J, Irvine GB, Johnston JA, Toft M, Mata IF, Kachergus J, Hulihan M, Taylor JP, Lincoln SJ, Farrer MJ, Lynch T, Mark Gibson J (2005)
    Clinical traits of LRRK2-associated Parkinson's disease in Ireland: a link between familial and idiopathic PD
    Parkinsonism Relat Disord, 11 (6), 349-52
    DOI 10.1016/j.parkreldis.2005.05.004, PubMed 16102999
  3. Haugen T, Toft M, Müller CR, Aasly J (2005)
    [Malignant hyperthermia--a hereditary and potentially life-threatening condition]
    Tidsskr Nor Laegeforen, 125 (20), 2792-4
    PubMed 16244682
  4. Kachergus J, Mata IF, Hulihan M, Taylor JP, Lincoln S, Aasly J, Gibson JM, Ross OA, Lynch T, Wiley J, Payami H, Nutt J, Maraganore DM, Czyzewski K, Styczynska M, Wszolek ZK, Farrer MJ, Toft M (2005)
    Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations
    Am J Hum Genet, 76 (4), 672-80
    DOI 10.1086/429256, PubMed 15726496
  5. Toft M, Farrer M (2005)
    Premutation alleles and fragile X-associated tremor/ataxia syndrome
    JAMA, 293 (3), 296; author reply 296-7
    DOI 10.1001/jama.293.3.296-a, PubMed 15657320
  6. Toft M, Mata IF, Kachergus JM, Ross OA, Farrer MJ (2005)
    LRRK2 mutations and Parkinsonism
    Lancet, 365 (9466), 1229-30
    DOI 10.1016/S0140-6736(05)74809-1, PubMed 15811454
  7. Toft M, Sando SB, Melquist S, Ross OA, White LR, Aasly JO, Farrer MJ (2005)
    LRRK2 mutations are not common in Alzheimer's disease
    Mech Ageing Dev, 126 (11), 1201-5
    DOI 10.1016/j.mad.2005.06.010, PubMed 16087219
  8. Toft M, Aasly J, Bisceglio G, Adler CH, Uitti RJ, Krygowska-Wajs A, Lynch T, Wszolek ZK, Farrer MJ (2005)
    Parkinsonism, FXTAS, and FMR1 premutations
    Mov Disord, 20 (2), 230-3
    DOI 10.1002/mds.20297, PubMed 15390127
  9. Aasly JO, Toft M, Fernandez-Mata I, Kachergus J, Hulihan M, White LR, Farrer M (2005)
    Clinical features of LRRK2-associated Parkinson's disease in central Norway
    Ann Neurol, 57 (5), 762-5
    DOI 10.1002/ana.20456, PubMed 15852371

Publications 2004

  1. Skipper L, Wilkes K, Toft M, Baker M, Lincoln S, Hulihan M, Ross OA, Hutton M, Aasly J, Farrer M (2004)
    Linkage disequilibrium and association of MAPT H1 in Parkinson disease
    Am J Hum Genet, 75 (4), 669-77
    DOI 10.1086/424492, PubMed 15297935
  2. Toft M, Aasly J (2004)
    [The genetics of Parkinson disease]
    Tidsskr Nor Laegeforen, 124 (7), 922-4
    PubMed 15060636
 
Page visits: 3683